Shopping Cart
Remove All
Your shopping cart is currently empty
Bintrafusp alfa (M7824) is a bifunctional fusion protein consisting of the extracellular structural domain of TGF-βRII (a TGF-β "trap") fused to a monoclonal antibody against human immunoglobulin G1 fused to programmed death ligand 1 (PD-L1), which is known for its anticancer activity, and can be used to study esophageal cancer. It has anticancer activity and can be used to study esophageal cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | - | In Stock | |
| 5 mg | $689 | - | In Stock | |
| 10 mg | $1,080 | - | In Stock |
| Description | Bintrafusp alfa (M7824) is a bifunctional fusion protein consisting of the extracellular structural domain of TGF-βRII (a TGF-β "trap") fused to a monoclonal antibody against human immunoglobulin G1 fused to programmed death ligand 1 (PD-L1), which is known for its anticancer activity, and can be used to study esophageal cancer. It has anticancer activity and can be used to study esophageal cancer. |
| In vitro | Bintrafusp alfa is capable of providing sustained protective immunity, reducing the function of regulatory T cells, significantly increasing the infiltration of CD8+ T cells and natural killer cells, while also decreasing the infiltration of bone marrow-derived suppressor cells within the tumor. [1] |
| Synonyms | MSB-0011359C, MSB0011359C, M-7824, M7824, GSK-4045154, GSK4045154 |
| Cas No. | 1918149-01-5 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.